Search academic texts

Information × Registration Number 0204U000034, 0101U000382 , R & D reports Title The efficacy and safety of novel medicine Tekom-A in treatment of patients with chronic inflammatory pulmonary diseases, complicated by blood hypercoagulation syndrome popup.stage_title Head Gavrisyuk Volodymyr, Registration Date 12-01-2004 Organization Institute of tuberculosis and pulmonology named by F. G. Yanovsky popup.description2 In order to compare the efficacy of Tekom and Tekom-A in terms of correction of haemostasis system in patients with chronic inflammatory diseases it was established that Tekom-A posessed more pronounced antiagregative effect. Clinical efficacy is higher in Tekom-A due to faster development of hypocoagulative effect. Application sphere - therapy, pulmonology Product Description popup.authors popup.nrat_date 2020-04-02 Close